Dasatinib 50 mg Tablet

Dasatinib 50 mg Tablet About

Introduction toSpnib 50mg Tablet

Spnib 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

The common side effects that are likely to associate with Spnib50mgtablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you.

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses ofSpnib 50mg Tablet

Spnib50mgtablet is indicated for the following conditions

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior.